Financial statements Instytut Biotechnologii Surowic I Szczepionek Biomed - Skrót Firmy Ibss Biomed S.a.
Balance sheet data of INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED - SKRÓT FIRMY IBSS BIOMED S.A.
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 309 341 165,74 | 334 213 739,55 | 428 725 526,69 | 557 721 373,36 | 457 383 827,39 | 714 461 764,53 |
A. Fixed assets | 245 516 622,86 | 250 161 558,82 | 371 479 625,51 | 483 787 570,12 | 385 571 634,58 | 630 322 903,37 |
B. Current assets | 63 650 042,88 | 83 870 180,73 | 57 057 401,18 | 73 745 303,24 | 71 601 192,81 | 83 927 861,16 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 174 500,00 | 182 000,00 | 188 500,00 | 188 500,00 | 211 000,00 | 211 000,00 |
Total liabilities | 309 341 165,74 | 334 213 739,55 | 428 725 526,69 | 557 721 373,36 | 457 383 827,39 | 714 461 764,53 |
A. Equity | 275 424 572,29 | 297 884 281,38 | 378 879 819,65 | 486 360 822,05 | 405 251 740,30 | 610 887 735,92 |
B. Liabilities and provisions for liabilities | 33 916 593,45 | 36 329 458,17 | 49 845 707,04 | 71 360 551,31 | 52 132 087,09 | 103 574 028,61 |
I. Long-term liabilities | 105 000,00 | 90 000,00 | 75 000,00 | 60 000,00 | 45 000,00 | 30 000,00 |
II. Short-term liabilities | 5 049 330,10 | 7 130 843,72 | 4 972 907,28 | 4 159 900,25 | 6 746 264,05 | 15 515 275,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.